コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 h pain during ambulation, which is known as "intermittent claudication".
2 ral times more common in the population than intermittent claudication.
3 ymptoms that are not consistent with classic intermittent claudication.
4 is recommended as a first-line treatment for intermittent claudication.
5 establish the role for revascularization in intermittent claudication.
6 ategies to improve mobility in patients with intermittent claudication.
7 ion, and leukocyte adhesion in patients with intermittent claudication.
8 ife after 1 year in unselected patients with intermittent claudication.
9 not an effective treatment for patients with intermittent claudication.
10 patients with peripheral artery disease and intermittent claudication.
11 formance or quality of life in patients with intermittent claudication.
12 scores of PAD participants with and without intermittent claudication.
13 s with peripheral arterial disease (PAD) and intermittent claudication.
14 se rates of ischemic events in patients with intermittent claudication.
15 ity-based physical activity in patients with intermittent claudication.
16 mproves walking performance in patients with intermittent claudication.
17 tinnitus but has some effect on dementia and intermittent claudication.
18 capacity in patients with moderate-to-severe intermittent claudication.
19 cipants with peripheral arterial disease had intermittent claudication.
20 erotic peripheral arterial disease (PVD) and intermittent claudication.
21 singly been used for patients with disabling intermittent claudication.
22 safe and well tolerated for the treatment of intermittent claudication.
23 l for treatment of stable, moderately severe intermittent claudication.
24 e heart failure, stroke, incident angina, or intermittent claudication.
25 e and acceptable treatment for patients with intermittent claudication.
26 improve morbidity, including the symptoms of intermittent claudication.
27 , and cardiovascular events in patients with intermittent claudication?
30 y in peripheral artery disease patients with intermittent claudication after a home-based exercise pr
32 e characteristics compared with persons with intermittent claudication and a sedentary, asymptomatic,
33 tified as having PAD at baseline if they had intermittent claudication and an ankle brachial index of
36 ents with stenosis or occlusion, symptoms of intermittent claudication, and maximum walking distance
37 ties, resulting in skeletal muscle ischemia, intermittent claudication, and, in more severe stages of
40 x <0.9 assessed at regular examinations, new intermittent claudication assessed by annual surveillanc
45 improves health-related quality of life and intermittent claudication distance after 1 year in patie
47 us placebo for 6 months in 133 subjects with intermittent claudication due to PAD in a single-center
49 5 subjects with unilateral exercise-limiting intermittent claudication during 2 qualifying treadmill
50 ivation, which can occur in the condition of intermittent claudication during exertion, an exaggerate
51 model was used to compute the probability of intermittent claudication for specified levels of risk f
52 rospectively followed 255 male patients with intermittent claudication from the CAVASIC Study during
53 th peripheral arterial disease (PAD) without intermittent claudication have been established as benef
54 ge, body mass index, diabetes mellitus, sex, intermittent claudication, heart rate, estimated glomeru
55 ssociations between respiratory diseases and intermittent claudication (i.e. pain in the leg during w
56 rterial disease patients included those with intermittent claudication (IC) (n = 23) and critical lim
57 ave occurred, but it remains unclear whether intermittent claudication (IC) incidence and mortality r
67 th a diagnosis of peripheral artery disease, intermittent claudication, leg revascularisation, and le
70 tension (n=2), worsening hypertension (n=1), intermittent claudication (n=1) and wound infection (n=1
71 ategorized into leg symptom groups including intermittent claudication (n=215) and always asymptomati
73 n a 2:1 ratio, 476 patients with symptomatic intermittent claudication or ischemic pain while at rest
74 randomized trial in which 331 patients with intermittent claudication or ischemic rest pain attribut
75 who subsequently developed symptomatic PAD (intermittent claudication or need for revascularization)
77 site of a primary end point event or angina, intermittent claudication, or transient ischemic attack;
78 0 lower extremities) with known or suspected intermittent claudication referred for lower extremity t
79 rasound assessment, unselected patients with intermittent claudication requesting treatment for claud
82 rhinitis without asthma was associated with intermittent claudication (RRR:4.63, 95% CI:1.72-12.5),
84 ient ischemic attack or stroke, a history of intermittent claudication, stenosis of 80 to 94 percent
85 ial with the aim to enroll 320 patients with intermittent claudication that does not respond to medic
86 cclusive peripheral arterial disease include intermittent claudication, that is, pain with walking, a
87 [8] years; 87% male, 37% with diabetes) with intermittent claudication were enrolled at medical cente
88 patients with peripheral artery disease with intermittent claudication who have not responded to medi
89 ery or angioplasty, limb or foot amputation, intermittent claudication with objective evidence of per
90 ts with peripheral artery disease experience intermittent claudication, with consequent loss of quali
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。